Multiple sclerosis trials in New Zealand

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  Where

  Auckland, Christchurch Central City

  Age

  18 years to 60 years

  People

  360 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07282574 · EU 2025-521636-10-00